CytoSelect 96-well Cell Migration and Invasion Assay (8 um), Fluorometric, Combo Kit
Référence MBS168493-2x96
Conditionnement : 2x96Assays
Marque : MyBiosource
Cytoselect Cell Migration and Invasion Assay (8 Um) Assay Kit
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS168493Background: Cell migration is a highly integrated, multistep process that orchestrates embryonic morphogenesis, tissue repair and regeneration. It plays a pivotal role in the disease progression of cancer, mental retardation, atherosclerosis, and arthritis.… More details
Product Overview
Online Datasheet in PDFProduct Name
CytoSelect Cell Migration and Invasion Assay (8 um), Assay Kit
Full Product Name
CytoSelect 96-well Cell Migration and Invasion Assay (8 um), Fluorometric, Combo Kit
Product Synonym Names
CytoSelect 96-well Cell Migration and Invasion Assay (8 um), Fluorometric, Combo Kit
Preparation and Storage
Store all components at 4 degree C until their expiration dates
Product Categories/Family for CytoSelect Cell Migration and Invasion Assay (8 um) assay kit
Cell Based Assays; Cell Migration; Invasion and Wound Healing; Boyden Chamber Assays; Chemotaxis/Cell Invasion Combo Kits
Product References and Citations for CytoSelect Cell Migration and Invasion Assay (8 um) assay kit
1. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. (2003) Science 302, 1704-9.
2. Horwitz R, Webb D. (2003) Curr Biol. 13, R756-9.
3. Lauffenburger DA, Horwitz AF. (1996) Cell 84, 359-369.
1. Sharma, N. L. et al. (2014). The ETS family member GABPalpha modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer. Nucleic Acids Res. 42:6256-6269.
2. Zecchini, V. et al. (2014). Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. EMBO J. 33:1365-1382.
3. Ardiani, A. et al. (2014). Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process. Cancer Res. 74:1945-1957.
4. Sharma, N.L. et al. (2014). The ETS family member GABPa modulates androgen receptor signaling and mediates an aggressive phenotype in prostate cancer. Nucleic Acids Res. 10.1093/nar/gku281.
5. Axlund, S.D. et al. (2010). HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Mol. Cancer Res. 8:1643-1655.
6. Alfano, R.W. et al. (2009). Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis. Mol. Cancer Res. 7:452-461.
7. Eckstein, N. et al. (2008). EGFR-pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 283:739-750.
2. Horwitz R, Webb D. (2003) Curr Biol. 13, R756-9.
3. Lauffenburger DA, Horwitz AF. (1996) Cell 84, 359-369.
1. Sharma, N. L. et al. (2014). The ETS family member GABPalpha modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer. Nucleic Acids Res. 42:6256-6269.
2. Zecchini, V. et al. (2014). Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. EMBO J. 33:1365-1382.
3. Ardiani, A. et al. (2014). Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process. Cancer Res. 74:1945-1957.
4. Sharma, N.L. et al. (2014). The ETS family member GABPa modulates androgen receptor signaling and mediates an aggressive phenotype in prostate cancer. Nucleic Acids Res. 10.1093/nar/gku281.
5. Axlund, S.D. et al. (2010). HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Mol. Cancer Res. 8:1643-1655.
6. Alfano, R.W. et al. (2009). Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis. Mol. Cancer Res. 7:452-461.
7. Eckstein, N. et al. (2008). EGFR-pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 283:739-750.
Other Notes
Small volumes of CytoSelect Cell Migration and Invasion Assay (8 um) assay kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for CytoSelect Cell Migration and Invasion Assay (8 um) purchase
MBS168493 is an assay kit targeting CytoSelect Cell Migration and Invasion Assay (8 um). Also known as CytoSelect 96-well Cell Migration and Invasion Assay (8 um), Fluorometric, Combo Kit.







